Transfer of Structures to New Business Opportunities for Pharmaceutical Machines
With the rapid development of China’s economy and people’s increasing demand for medical care, the demand for pharmaceutical quality has also gradually increased. At the same time, China’s adjustment of product structure changes and growth methods will both promote the rapid development of China’s pharmaceutical industry and indirectly drive it. The new rise of China's pharmaceutical equipment and packaging equipment and materials industry.
Reviewing the Development of Pharmaceutical Equipment and Pharmaceutical Packaging Industry in China in Recent Years
In 1999, the implementation of the GMP (Pharmaceutical Production Quality Management) Regulations required a large number of pharmaceutical equipment manufacturers to upgrade their pharmaceuticals and provide opportunities for the development of the pharmaceutical industry in China, bringing the industry to its first “golden†period. In the five-year transition period in 2004, the number of pharmaceutical equipment companies has doubled. However, with the GMP certification of drug manufacturers coming to an end, pharmaceutical equipment companies and drug manufacturers have created a situation where supply exceeds demand.
According to incomplete statistics, there are more than 600 pharmaceutical equipment companies in China with more than 3,000 kinds of product specifications. In addition to fully satisfying the needs of Chinese and Western medicine factories, animal medicine factories and health products factories, the products are also exported to more than 60 countries and area. According to statistics from the National Bureau of Statistics, between January and November 2010, 380 large-scale enterprises in China's pharmaceutical equipment industry achieved sales revenue of 37.724 billion, up by 27.45% year-on-year; sales profit was 3.238 billion, up by 24.38% year-on-year; and the completed export delivery value was 14.984 billion. The year-on-year increase of 21.52%; the completion of taxes 1.259 billion, an increase of 28.68%; capital preservation and appreciation rate of 124.13%; debt ratio of 44.81%. Of these, 53 companies suffered losses with a loss of 74.88 million.
At present, there are about 1,500 companies in the pharmaceutical packaging industry in China. According to expert analysis, the total industrial output value reached 35 billion in 2010, accounting for less than 3% of the total output value of China's pharmaceutical industry, and far below the level of 30% in developed countries.
The new GMP implementation is the second “golden†opportunity for the development of pharmaceutical equipment and pharmaceutical packaging industry in China
On March 1, 2011, the “Standards for Quality Control of Pharmaceutical Production (Revised in 2010)†was formally implemented. The new version of GMP is based on European and American GMP certification standards, raises the threshold of the industry, and places higher requirements on the software and hardware of pharmaceutical companies. Pharmaceutical equipment has made detailed provisions to regulate the installation, use, and maintenance of pharmaceutical equipment.
According to statistics, China currently has more than 4,000 small and medium-sized pharmaceutical companies. To meet the requirements of the new GMP standards, these companies will need to invest considerable money to update some of the pharmaceutical equipment. This will be for domestic and foreign pharmaceutical equipment and pharmaceutical packaging companies. The new and rare business opportunity is the second “golden†opportunity period for the development of the pharmaceutical equipment and pharmaceutical packaging industry.
Intake Manifold And Filter,Industry Intake Manifold,Four Cylinder Engine,Cylinder Engine Intake Manifold
Zhejiang Noken Mechanical Technology Co., LTD , https://www.nkcasting.com